freelance science journalist and author
From The Saturday Paper, 5 July 2025: Standing ovations are rare at scientific conferences. Infectious diseases physician Professor Sharon Lewin, director of the Peter Doherty Institute for Infection and Immunity in Melbourne, still gets “tingly” at the memory of about 10,000 attendees surging to their feet at the 25th International AIDS Conference in Munich a … Continue reading Will miracle HIV drug go on the PBS?
From Skin and Allergy News, 21 July 2014: Treatment with the interferon-free oral nucleotide analog sofosbuvir plus ribavirin achieved high rates of sustained virologic response in patients with HIV coinfected with hepatitis C, according to data from an open-label phase III study. Researchers observed an 82% response rate among treatment-naive patients coinfected with hepatitis C … Continue reading Sofosbuvir achieves sustained response in patients with hepatitis C and HIV
From Family Practice News, 21 July 2014: Allogeneic hematopoietic stem cell transplantation from HIV-naive individuals to HIV-1–positive individuals may achieve temporary antiretroviral-free remission of infection and loss of detectable HIV-1, a study showed. Two men with chronic HIV-1 infection received allogeneic hematopoietic stem cell transplants (HSCTs) from susceptible donors to treat Hodgkin’s and non-Hodgkin’s lymphoma, … Continue reading Stem cell transplantation achieved temporary HIV remission
Bianca Nogrady 